Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
03 May 2019 | Story Ruan Bruwer
Lynique Beneke
Lynique Beneke, long jump athlete of the University of the Free State and the national women’s champion seven times in a row, hopes to qualify for the World Championships.
The long jumper, Lynique Beneke, dreams of going to another Olympic Games and jumping over seven metres before she retires.

In between, there is still a World Championship later in the year for which she is trying to qualify. The qualifying standard is 6,72 m, not far from the 6,64 m she achieved at the national athletics championships at the end of April, which earned her a seventh consecutive national crown. At the time, it was the seventh best globally. She will have to qualify in Europe, as the South African season is over.

“With my faith as my biggest support, my mom and I both dreamed about me jumping exactly the same distance of 7,03 m! That is my big goal. I know I can do that,” Beneke (28) said. Her personal best is 6,81 m.

Special bond with coach

She is currently studying Education (BEd Senior and FET phase). “At this moment, I’m focusing on finishing my degree and enjoying my athletics. I want to give my athletics a fair chance, as I am only getting into prime shape now at this age. Once I’m done with athletics, I will focus on a career.”

According to Beneke, a 2016 Olympian and the Kovsie Senior Sportswoman of the Year for 2018, consistency is the name of her game. “I show up, even when I don’t feel like it. I push myself every day. I feel I have so much left in the tank, and that motivates me. All the glory to God.”

She is married to the hurdler, PC (also a Kovsie student). They moved from Gauteng to Bloemfontein at the end of 2017.

“My coach, Emmarie Fouché, was the big influence (coming here). I started working with her at the end of 2015. We work perfectly together; we are both women and have the same work ethic. She understands me. We are very close, and I think that is what makes the difference.”


News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept